by Brandon Tudor | Mar 5, 2026 | Blog
From 02/23/2026, an article that highlights the overlap between kidney stones and MASLD: “Association between metabolic dysfunction-associated steatotic liver disease and kidney stone risk in individuals with metabolic dysfunction: evidence from cross-sectional...
by Pete Celano | Mar 4, 2026 | Blog
Consider “Association of food insecurity with MASLD prevalence and liver-related mortality” from the Journal of Hepatology, 2025. The Net Net The study shows that food insecurity is strongly linked to the global prevalence of metabolic dysfunction–associated steatotic...
by Brandon Tudor | Mar 2, 2026 | Blog
A summary of the Clinical Gastroenterology and Hepatology article with DOI S1542-3565(24)00989-3, titled Food Swamps and Food Deserts Impact on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) follows.It speaks to how Liver Disease triage, diagnosis...
by Pete Celano | Feb 27, 2026 | Blog
Liver Cancer, like every cancer, is more treatable if diagnosed early. But it’s not easy, because it typically remains asymptomatic in the early stages. LiverRight providers diagnose Liver Cancer in adults, of which there are two types–1. Hepatocellular...
by Pete Celano | Feb 25, 2026 | Blog
1️⃣ The Governing Structure: ABIM In the U.S., specialty certification is governed by: American Board of Internal Medicine (ABIM)Under the umbrella of the American Board of Medical Specialties (ABMS) Hepatology is not an independent primary subspecialty.It is...
by Brandon Tudor | Feb 23, 2026 | Blog
Here are the top 10 liver-related events (LREs) commonly used in clinical research and outcome studies of chronic liver disease. “LREs” refer to major clinical complications and outcomes that indicate progression of liver disease and substantially impact prognosis,...
